Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples